MUC16 Retention after Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma is a research paper published in Cancers (2024). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
the Fred and Pamela Buffett Cancer Center
Grant: R01 CA259080
the Fred and Pamela Buffett Cancer Center
Grant: P50 CA127297
the Fred and Pamela Buffett Cancer Center
Grant: P30 CA036727
the Fred and Pamela Buffett Cancer Center
Grant: LB595
National Institutes of Health
Grant: 5P50CA127297-05
P-4: Inhibitors of telomerase in treatment of Pancreatic Adenocarcinoma
National Institutes of Health
Grant: 5R01CA259080-02
Preclinical development of a novel antibody conjugate for intraoperative detection of pancreatic cancer
National Institutes of Health
Grant: 5P30CA036727-23
CORE--Confocal Microscopy
FWCI
0.00
Citation Percentile
0.2%
Fields of Study
Keywords
Sustainable Development Goals